An agent known as zafirlukast functions as an inhibitor, effectively blocking the binding of leukotrienes to cell receptors. When taken consistently over a period of time, zafirlukast can assist in reducing or preventing symptoms associated with asthma. By impeding the interaction between leukotrienes and their receptors, this medication helps mitigate the inflammatory responses in the airways, promoting improved respiratory function and minimizing asthma-related discomfort. It is important to note that zafirlukast should be used as prescribed by a healthcare professional, and regular follow-ups are essential to assess its efficacy and ensure appropriate asthma management.
A medication known as a leukotriene receptor antagonist is employed to prevent asthma.